Alerts will be sent to your verified email
Verify Email
ANG
|
ANG Lifesciences
|
Vineet Laboratories
|
Deccan Health Care
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
3.78 % | -20.75 % | 0.79 % |
|
5yr average Equity Multiplier
|
3.3 | 4.27 | 1.17 |
|
5yr Average Asset Turnover Ratio
|
0.77 | 1.52 | 0.47 |
|
5yr Avg Net Profit Margin
|
-2.26 % | -4.28 % | 1.37 % |
|
Price to Book
|
0.66 | 2.74 | 0.36 |
|
P/E
|
0.0 | 0.0 | 27.52 |
|
5yr Avg Cash Conversion Cycle
|
70.26 Days | 179.8 Days | 218.27 Days |
|
Inventory Days
|
107.37 Days | 114.74 Days | 372.92 Days |
|
Days Receivable
|
274.82 Days | 109.14 Days | 54.52 Days |
|
Days Payable
|
235.98 Days | 115.29 Days | 94.94 Days |
|
5yr Average Interest Coverage Ratio
|
1.81 | 1.29 | 12.96 |
|
5yr Avg ROCE
|
15.08 % | -1.66 % | 2.08 % |
|
5yr Avg Operating Profit Margin
|
7.68 % | -0.62 % | 7.39 % |
|
5 yr average Debt to Equity
|
0.97 | 1.24 | 0.02 |
|
5yr CAGR Net Profit
|
n/a | n/a | 24.36 % |
|
5yr Average Return on Assets
|
1.04 % | -2.52 % | 0.68 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
70.6 % | 15.89 % | 18.42 % |
|
Share Pledged by Promoters
|
44.88 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.55 % | -20.07 % | -9.18 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
ANG Lifesciences
|
Vineet Laboratories
|
Deccan Health Care
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|